Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Predictive Analytics Help Identify Drug Candidate Molecules

Posted on January 26th, 2019 by in Pharma R&D

The process of discovering a viable drug candidate molecule is often time-consuming and research-intensive. A lab must test thousands of compounds every day — and a hit rate of just 1 percent is considered above average. Continue reading “Predictive Analytics Help Identify Drug Candidate Molecules” »

Government Shutdown Could Have Lasting Impact on Scientific Research

Posted on January 26th, 2019 by in Pharma R&D

The U.S. government shutdown dragged on past the one-month mark, creating financial panic for many government workers and resulting in a ripple of negative affects across the country. Continue reading “Government Shutdown Could Have Lasting Impact on Scientific Research” »

Pharma Industry Associations Air Their Concerns Following Rejection of Brexit Deal

Posted on January 23rd, 2019 by in Pharma R&D

There has always been a special relationship between the United States and the United Kingdom that gives the two nations a unique connection. Unfortunately, lately, the two have also shared quite a bit of upheaval and uncertainty in their respective governments. Continue reading “Pharma Industry Associations Air Their Concerns Following Rejection of Brexit Deal” »

Growth, recognition, results—and an important partnership

Posted on January 17th, 2019 by in Pharma R&D

Here at Sigilon Therapeutics, we have had a very exciting period of growth recently, including receiving an Advanced Therapy Medicinal Product (ATMP) designation from the European Medicines Agency, adding two new members to our leadership team and initiating a collaboration with Eli Lilly in type 1 diabetes. Continue reading “Growth, recognition, results—and an important partnership” »

  1. 1
  2. 2